US-based biotech multinational Thermo Fisher Scientific has successfully issued CHF 1.425 billion in bonds under Swiss law. The transaction, structured across five tranches, represents the largest Swiss franc bond issuance by a US corporate to date.
The bonds have been provisionally admitted to trading, with an application for definitive admission and listing on the SIX Swiss Exchange already filed.
UBS Investment Bank, BNP Paribas (Suisse) and Deutsche Bank’s London Branch (acting through its Zurich Branch) acted as lead managers in the issuance.